Requirement for analgesia ‐ not reported · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (hot flushes) · women with uterine fibroids
1 finding from 1 review
Proportion given local anaesthesia (%) · heavy menstrual bleeding
It is very uncertain whether overall analyses: second‐generation endometrial ablation changes proportion given local anaesthesia (%) compared with first‐generation endometrial ablation (very low certainty).
1 finding from 1 review
Adverse events (hot flushes) · women with uterine fibroids
GnRHa treatment may leads to higher adverse events (hot flushes) compared with other medical therapies before any surgery (low certainty).
1 finding from 1 review
Harms: Adhesions at 6 months ‐ LOD vs THL N of participants: 246 (1 RCT) · Women with symptoms of PCOS
It is very uncertain whether LOD changes harms: Adhesions at 6 months ‐ LOD vs THL N of participants: 246 (1… compared with other surgical interventions (very low certainty).
1 finding from 1 review
OR 0.1 [0.05, 0.18]
Studies not reported
Very low
Harms: Adhesions at 6 months ‐ LOD vs THL N of participants: 246 (1 RCT) · Women with symptoms of PCOS
It is very uncertain whether LOD changes harms: Adhesions at 6 months № of participants: 64 (1 study) compared with LOD variable energy (very low certainty).
1 finding from 1 review
OR 0.96 [0.32, 2.88]
Studies not reported
Very low
Side effects ‐ hot flushes · women with symptomatic endometriosis
It is very uncertain whether gestrinone changes side effects: hot flushes compared with danazol (very low certainty).
1 finding from 1 review
Side effects ‐ hot flushes · women with symptomatic endometriosis
Gestrinone may leads to lower side effects: hot flushes compared with leuprolin (low certainty).
1 finding from 1 review
Side effects ‐ hot flushes · women with symptomatic endometriosis
Mifepristone leads to higher side effects: hot flushes compared with placebo (high certainty).
1 finding from 1 review
Vasomotor SymptomsFrequency of hot flushes measured in a diary (daily) · women with menopausal symptoms
1 finding from 1 review
Vasomotor SymptomsSeverity of hot flushes measured in a diary (daily) · women with menopausal symptoms
1 finding from 1 review
Vasomotor SymptomsOverall scores of hot flushes in a diary (daily) · women with menopausal symptoms
1 finding from 1 review
Vasomotor SymptomsOverall scores of hot flushes in a diary (monthly) · women with menopausal symptoms
1 finding from 1 review
Severity of vasomotor symptoms · patients with uterine fibroids
1 finding from 1 review
Change in hot flushes/night sweats Self‐report · women with vasomotor menopausal symptoms
1 finding from 1 review
Change in hot flushes/night sweats Self‐report · women with vasomotor menopausal symptoms
1 finding from 1 review
Intervention not reported
Change in number of hot flushes/24 h ( · perimenopausal and postmenopausal women with vasomotor symptoms
1 finding from 1 review
Intervention not reported
Improvement in severity of hot flushes ( · perimenopausal and postmenopausal women with vasomotor symptoms
1 finding from 1 review
Side effects ‐ hot flushes · patients with pain associated with endometriosis
Oral progestagens may leads to lower side effects ‐ hot flushes compared with other treatment (low certainty).
1 finding from 1 review
Side effects ‐ hot flushes · patients with pain associated with endometriosis
It is very uncertain whether anti‐progestagen changes side effects ‐ hot flushes compared with other treatment (very low certainty).
1 finding from 1 review